Logo image of ACLS

AXCELIS TECHNOLOGIES INC (ACLS) Stock Fundamental Analysis

USA - NASDAQ:ACLS - US0545402085 - Common Stock

91.1 USD
+1.29 (+1.44%)
Last: 9/17/2025, 8:21:30 PM
92.25 USD
+1.15 (+1.26%)
Pre-Market: 9/18/2025, 6:31:01 AM
Fundamental Rating

7

Taking everything into account, ACLS scores 7 out of 10 in our fundamental rating. ACLS was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS gets an excellent profitability rating and is at the same time showing great financial health properties. ACLS is not valued too expensively and it also shows a decent growth rate. These ratings would make ACLS suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ACLS had positive earnings in the past year.
ACLS had a positive operating cash flow in the past year.
Each year in the past 5 years ACLS has been profitable.
ACLS had a positive operating cash flow in each of the past 5 years.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

The Return On Assets of ACLS (11.97%) is better than 83.04% of its industry peers.
With an excellent Return On Equity value of 15.50%, ACLS belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
The Return On Invested Capital of ACLS (12.23%) is better than 83.93% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACLS is significantly above the industry average of 10.87%.
The last Return On Invested Capital (12.23%) for ACLS is well below the 3 year average (21.34%), which needs to be investigated, but indicates that ACLS had better years and this may not be a problem.
Industry RankSector Rank
ROA 11.97%
ROE 15.5%
ROIC 12.23%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ACLS's Profit Margin of 17.69% is fine compared to the rest of the industry. ACLS outperforms 79.46% of its industry peers.
ACLS's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 17.81%, ACLS is doing good in the industry, outperforming 75.89% of the companies in the same industry.
ACLS's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 44.90%, ACLS perfoms like the industry average, outperforming 51.79% of the companies in the same industry.
In the last couple of years the Gross Margin of ACLS has remained more or less at the same level.
Industry RankSector Rank
OM 17.81%
PM (TTM) 17.69%
GM 44.9%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACLS is creating value.
ACLS has less shares outstanding than it did 1 year ago.
ACLS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ACLS has been reduced compared to a year ago.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 8.10 indicates that ACLS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.10, ACLS is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
The Debt to FCF ratio of ACLS is 0.35, which is an excellent value as it means it would take ACLS, only 0.35 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.35, ACLS belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
ACLS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
ACLS has a better Debt to Equity ratio (0.04) than 60.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Altman-Z 8.1
ROIC/WACC1.07
WACC11.4%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

ACLS has a Current Ratio of 6.01. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
ACLS has a Current ratio of 6.01. This is amongst the best in the industry. ACLS outperforms 83.93% of its industry peers.
ACLS has a Quick Ratio of 4.26. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ACLS (4.26) is better than 74.11% of its industry peers.
Industry RankSector Rank
Current Ratio 6.01
Quick Ratio 4.26
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for ACLS have decreased strongly by -28.37% in the last year.
Measured over the past years, ACLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 64.54% on average per year.
The Revenue for ACLS has decreased by -19.38% in the past year. This is quite bad
ACLS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.30% yearly.
EPS 1Y (TTM)-28.37%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-27.1%
Revenue 1Y (TTM)-19.38%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-24.16%

3.2 Future

The Earnings Per Share is expected to grow by 24.02% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -4.79% on average over the next years.
EPS Next Y-31.52%
EPS Next 2Y-17.23%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue Next Year-22.15%
Revenue Next 2Y-9.31%
Revenue Next 3Y-4.79%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.52 indicates a rather expensive valuation of ACLS.
Based on the Price/Earnings ratio, ACLS is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.20, ACLS is valued a bit cheaper.
With a Price/Forward Earnings ratio of 21.62, ACLS is valued on the expensive side.
ACLS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ACLS is cheaper than 73.21% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.70. ACLS is around the same levels.
Industry RankSector Rank
PE 17.52
Fwd PE 21.62
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACLS is valued cheaply inside the industry as 91.07% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACLS indicates a rather cheap valuation: ACLS is cheaper than 84.82% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.3
EV/EBITDA 11.21
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The excellent profitability rating of ACLS may justify a higher PE ratio.
A more expensive valuation may be justified as ACLS's earnings are expected to grow with 24.02% in the coming years.
PEG (NY)N/A
PEG (5Y)0.27
EPS Next 2Y-17.23%
EPS Next 3Y24.02%

0

5. Dividend

5.1 Amount

No dividends for ACLS!.
Industry RankSector Rank
Dividend Yield N/A

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (9/17/2025, 8:21:30 PM)

Premarket: 92.25 +1.15 (+1.26%)

91.1

+1.29 (+1.44%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/amc
Inst Owners104.93%
Inst Owner Change-0.82%
Ins Owners0.94%
Ins Owner Change9.53%
Market Cap2.86B
Analysts72.86
Price Target99.26 (8.96%)
Short Float %14.79%
Short Ratio9.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)107.85%
Min EPS beat(2)51.76%
Max EPS beat(2)163.95%
EPS beat(4)4
Avg EPS beat(4)59.67%
Min EPS beat(4)2.16%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)36.38%
EPS beat(12)12
Avg EPS beat(12)29.49%
EPS beat(16)16
Avg EPS beat(16)28.03%
Revenue beat(2)2
Avg Revenue beat(2)2.57%
Min Revenue beat(2)2.12%
Max Revenue beat(2)3.02%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)3.02%
Revenue beat(8)7
Avg Revenue beat(8)1.46%
Revenue beat(12)11
Avg Revenue beat(12)2.07%
Revenue beat(16)15
Avg Revenue beat(16)2.39%
PT rev (1m)11.71%
PT rev (3m)18.51%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)35.67%
EPS NY rev (1m)25.39%
EPS NY rev (3m)24.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.09%
Revenue NY rev (1m)4.31%
Revenue NY rev (3m)4.4%
Valuation
Industry RankSector Rank
PE 17.52
Fwd PE 21.62
P/S 3.19
P/FCF 23.3
P/OCF 20.69
P/B 2.8
P/tB 2.8
EV/EBITDA 11.21
EPS(TTM)5.2
EY5.71%
EPS(NY)4.21
Fwd EY4.62%
FCF(TTM)3.91
FCFY4.29%
OCF(TTM)4.4
OCFY4.83%
SpS28.52
BVpS32.54
TBVpS32.54
PEG (NY)N/A
PEG (5Y)0.27
Profitability
Industry RankSector Rank
ROA 11.97%
ROE 15.5%
ROCE 13.92%
ROIC 12.23%
ROICexc 23.5%
ROICexgc 23.5%
OM 17.81%
PM (TTM) 17.69%
GM 44.9%
FCFM 13.71%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ROICexc(3y)45.35%
ROICexc(5y)37.49%
ROICexgc(3y)45.35%
ROICexgc(5y)37.49%
ROCE(3y)24.29%
ROCE(5y)20.95%
ROICexcg growth 3Y-3.61%
ROICexcg growth 5Y39%
ROICexc growth 3Y-3.61%
ROICexc growth 5Y39%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Debt/EBITDA 0.24
Cap/Depr 91.25%
Cap/Sales 1.73%
Interest Coverage 250
Cash Conversion 78.35%
Profit Quality 77.5%
Current Ratio 6.01
Quick Ratio 4.26
Altman-Z 8.1
F-Score6
WACC11.4%
ROIC/WACC1.07
Cap/Depr(3y)109.12%
Cap/Depr(5y)96.53%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.41%
Profit Quality(3y)77.07%
Profit Quality(5y)99.84%
High Growth Momentum
Growth
EPS 1Y (TTM)-28.37%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-27.1%
EPS Next Y-31.52%
EPS Next 2Y-17.23%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.38%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-24.16%
Revenue Next Year-22.15%
Revenue Next 2Y-9.31%
Revenue Next 3Y-4.79%
Revenue Next 5YN/A
EBIT growth 1Y-38.8%
EBIT growth 3Y18.31%
EBIT growth 5Y54.17%
EBIT Next Year-45.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-49.07%
FCF growth 3Y-3.13%
FCF growth 5YN/A
OCF growth 1Y-45.47%
OCF growth 3Y-2.13%
OCF growth 5YN/A